A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban

Riley Dean, Alison M. Messer, Melanie Pickett, Richard Jahan-Tigh

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Cutaneous leukocytoclastic vasculitis (LCV) is type of small vessel vasculitis that commonly presents as palpable purpura involving the lower extremities and buttocks. Approximately half of cases are idiopathic, but the disease may be triggered by infection, drug reaction, inflammatory disease, or other causes. We report a case of leukocytoclastic vasculitis secondary to the novel anticoagulant rivaroxaban (Xarelto®).

Original languageEnglish (US)
Article number19
JournalDermatology online journal
Volume23
Issue number11
StatePublished - Nov 2017
Externally publishedYes

Keywords

  • Leukocytoclastic vasculitis
  • Novel anticoagulant
  • Rash
  • Rivaroxaban
  • Xarelto

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban'. Together they form a unique fingerprint.

Cite this